Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.

Lucira Health, Inc.

Visby Medical is a molecular diagnostics company that provides portable PCR testing technology to deliver rapid infectious disease testing for healthcare providers.

Visby Medical

IBS Inc. leverages technology to develop drug testing and biosensor solutions that aim to improve quality of life. Self-described as pioneering pain-free solutions.

IBS Inc.

Lucira Health is a self-described molecular diagnostics company that develops and commercializes at-home molecular diagnostic tests for infectious diseases.

Metric
Company Name	Lucira Health, Inc.	Visby Medical	IBS Inc.
Symbol	LHDX
MSH ID	COM:LUCIRAHEALTH	COM:VISBYMEDICAL	INC:IBS
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Devices	Medical Devices	Medical Technology
Country	US	US	US
Stage
Employee Count	221		19
Website	lucirahealth.com	visbymedical.com	ibs.inc
LinkedIn
Founders

Metric
Market Cap	18.36M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	93.06M
Revenue (LTM)
Revenue (NTM)
Gross Profit	10.22M
EBITDA	-60.85M
Operating Income	-64.54M
Net Income	-64.83M
EPS	-1.86
Diluted EPS	-1.86
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.11
Operating Profit Margin	-0.69
EBITDA Margin	-0.65
Net Profit Margin	-0.70
Return on Equity	-1.02
Return on Assets	-0.27
Return on Capital Employed	-0.34

COM:LUCIRAHEALTH

Lucira Health

Last Close

0.45

03/03 21:00

Market Cap

18.36M

Beta: -

Volume Today

36.26M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-0.13
P/B Ratio	0.30
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.20
EV Multiple	-2.00

Metric
Days Sales Outstanding	46.45
Days Payables Outstanding	45.34
Days Inventory Outstanding	223.75
Operating Cycle	362.73
Cash Conversion Cycle	277.37
Asset Turnover	0.39

Metric
Operating Cash Flow	-100.88M
Free Cash Flow	-116.27M
Cash Flow to Debt	-35.66
Operating Cash Flow/Sales	-1.08
Free Cash Flow Yield	-5.10

Metric
Cash & Equivalents	105.98M
Accounts Receivable	-27.31M
Inventory	50.78M
Goodwill
Debt to Capitalization	0.01
Debt to Assets	0.25
Current Ratio	1.46
Quick Ratio	2.81

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.04
R&D to Revenue	0.21
SG&A to Revenue